CHEK1 and non-small cell lung carcinoma: Our previous HDACI study in acute myeloid leukemia cells (unpublished data) as well as studies by others in non-small cell lung cancer cells [19] have demonstrated that panobinostat treatments result in down-regulation of CHK1.